Literature DB >> 19716772

En bloc resection of primary tumors of the cervical spine: report of two cases and systematic review of the literature.

Jordan M Cloyd1, Dean Chou, Vedat Deviren, Christopher P Ames.   

Abstract

BACKGROUND CONTEXT: Survival data and rates of recurrence after en bloc resection for cervical spinal tumors are limited to single case reports and small case series, making the true risk of recurrence after this procedure unknown.
PURPOSE: To report two cases of cervical chordoma managed via en bloc resection. To conduct a systematic review of the existing literature to determine the overall incidence of disease-free survival and investigate potential prognostic factors of recurrence. STUDY
DESIGN: Case report and systematic review.
METHODS: We present the cases of a 60-year-old woman and a 76-year-old man who underwent en bloc resection of C3-C6 and C2 chordomas, respectively. A complete MEDLINE search was then undertaken for all articles reporting survival data for en bloc resections of primary tumors of the cervical spine. Exclusion criteria included non-English articles, lack of explicit mention or description of en bloc technique, age less than 16, no demographic or survival information reported, and follow-up less than 1 month. Survivorship analysis was conducted, and Kaplan-Meier plots were created with the primary outcome of interest being any tumor recurrence.
RESULTS: A total of 10 articles comprising 18 cases were included for analysis with a mean follow-up of 47.4+/-41.5 months. Mean operative time, estimated blood loss, and length of hospitalization were 18.6 hours, 2.9L, and 34.6 days, respectively. Postoperative complications occurred in eight of the nine patients in which these data were reported. There were three cases of local recurrence, occurring at 12, 44, and 113 months, and one case of distant metastasis, occurring at 12 months postoperatively. With the available data, 1- and 5-year disease-free survival rates of 88.2% and 73.5% were calculated. On Cox proportional hazards analysis, no factors were found to be predictive of recurrence.
CONCLUSIONS: In this systematic review of the literature, en bloc resection provided good disease-free survival rates in patients with primary tumors of the cervical spine. However, there are insufficient data on long-term subjective outcomes in these patients, and larger series are needed to determine the efficacy compared with piecemeal resection techniques. Other investigators should be encouraged to publish their results so that combined analyses like these may be performed with larger sample sizes.

Entities:  

Mesh:

Year:  2009        PMID: 19716772     DOI: 10.1016/j.spinee.2009.07.005

Source DB:  PubMed          Journal:  Spine J        ISSN: 1529-9430            Impact factor:   4.166


  11 in total

Review 1.  Health-Related Quality of Life After Spine Surgery for Primary Bone Tumour.

Authors:  Raphaële Charest-Morin; Nicolas Dea; Charles G Fisher
Journal:  Curr Treat Options Oncol       Date:  2016-02

2.  Mobile spine chordoma: results of 166 patients from the AOSpine Knowledge Forum Tumor database.

Authors:  Ziya L Gokaslan; Patricia L Zadnik; Daniel M Sciubba; Niccole Germscheid; C Rory Goodwin; Jean-Paul Wolinsky; Chetan Bettegowda; Mari L Groves; Alessandro Luzzati; Laurence D Rhines; Charles G Fisher; Peter Pal Varga; Mark B Dekutoski; Michelle J Clarke; Michael G Fehlings; Nasir A Quraishi; Dean Chou; Jeremy J Reynolds; Richard P Williams; Norio Kawahara; Stefano Boriani
Journal:  J Neurosurg Spine       Date:  2015-12-18

3.  Operative technique for en bloc resection of upper cervical chordomas: extended transoral transmandibular approach and multilevel reconstruction.

Authors:  Luis Alberto Ortega-Porcayo; Eibar Ernesto Cabrera-Aldana; Nicasio Arriada-Mendicoa; Juan Luis Gómez-Amador; Martín Granados-García; Juan Barges-Coll
Journal:  Asian Spine J       Date:  2014-12-17

4.  Total spondylectomy of C2 and circumferential reconstruction via combined anterior and posterior approach to cervical spine for axis tumor surgery.

Authors:  Wei Wu; Feng Li; Zhong Fang; Wei Xiong; Han-Feng Guan; Jun Xiao; Feng-Jin Guo; An-Min Chen
Journal:  J Huazhong Univ Sci Technolog Med Sci       Date:  2013-02-08

5.  Cervical subtotal en-bloc spondylectomy of C6 mesenchymal chondrosarcoma.

Authors:  Chang-Hwa Lee; Woo-Kie Min
Journal:  Eur Spine J       Date:  2015-11-10       Impact factor: 3.134

6.  En bloc resection of a C2-C3 upper cervical chordoma: Technical note.

Authors:  Alexander G Weil; Mohammed Shehadeh; Tareck Ayad; Olivier Abboud; Daniel Shedid
Journal:  Surg Neurol Int       Date:  2015-11-25

7.  Evaluation of Risk Factors for Vertebral Compression Fracture after Carbon-Ion Radiotherapy for Primary Spinal and Paraspinal Sarcoma.

Authors:  Yoshihiro Matsumoto; Makoto Shinoto; Makoto Endo; Nokitaka Setsu; Keiichiro Iida; Jun-Ichi Fukushi; Kenichi Kawaguchi; Seiji Okada; Hirofumi Bekki; Reiko Imai; Tadashi Kamada; Yoshiyuki Shioyama; Yasuharu Nakashima
Journal:  Biomed Res Int       Date:  2017-07-26       Impact factor: 3.411

8.  Dedifferentiated chondrosarcoma of the cervical spine: a case report.

Authors:  Yoshihiro Matsumoto; Yusuke Takahashi; Katsumi Harimaya; Takeshi Nakagawa; Kenichi Kawaguchi; Seiji Okada; Mitsumasa Hayashida; Toshio Doi; Akio Sakamoto; Tomoya Matsunobu; Yoshinao Oda; Yukihide Iwamoto
Journal:  World J Surg Oncol       Date:  2013-02-02       Impact factor: 2.754

Review 9.  Palliative Surgery in Treating Painful Metastases of the Upper Cervical Spine: Case Report and Review of the Literature.

Authors:  Xinghuo Wu; Zhewei Ye; Feifei Pu; Songfeng Chen; Baichuan Wang; Zhicai Zhang; Cao Yang; Shuhua Yang; Zengwu Shao
Journal:  Medicine (Baltimore)       Date:  2016-05       Impact factor: 1.889

Review 10.  Total spondylectomy of recurrent giant cell tumors in the cervical spine: Two case reports and review of literature.

Authors:  Ji Tu; Wentian Li; Shenglei Shu; Yukun Zhang; Wenbin Hua; Shuai Li; Shuhua Yang; Cao Yang
Journal:  Medicine (Baltimore)       Date:  2018-05       Impact factor: 1.889

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.